iQure Pharma Inc. research brief

CIK 1996977 Copy CIK

Generated Nov. 2, 2026, 2:09 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: SKILLMAN NJ. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• Sept. 21, 2026 · D/A · 0001996977-26-000002 · Source evidence

  Reported offering amount: 4000000 USD. Reported amount sold: 2788315 USD.

• June 3, 2026 · D · 0001996977-26-000001 · Source evidence

  Reported offering amount: 4000000 USD. Reported amount sold: 650000 USD.

• Nov. 3, 2025 · D · 0001996977-25-000003 · Source evidence

  Reported offering amount: 1750000 USD. Reported amount sold: 1503320 USD.

• Jan. 16, 2025 · D · 0001996977-25-000001 · Source evidence

  Reported offering amount: 1443786 USD. Reported amount sold: 1443786 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “iQure Pharma Inc. research brief,” CIK 1996977, retrieved Nov. 2, 2026, 2:09 p.m.. Cite the specific accessions used. No amounts have been summed.